318 related articles for article (PubMed ID: 25868730)
1. D-Aspartate: An endogenous NMDA receptor agonist enriched in the developing brain with potential involvement in schizophrenia.
Errico F; Mothet JP; Usiello A
J Pharm Biomed Anal; 2015 Dec; 116():7-17. PubMed ID: 25868730
[TBL] [Abstract][Full Text] [Related]
2. New insights on the role of free D-aspartate in the mammalian brain.
Errico F; Napolitano F; Nisticò R; Usiello A
Amino Acids; 2012 Nov; 43(5):1861-71. PubMed ID: 22851050
[TBL] [Abstract][Full Text] [Related]
3. The Emerging Role of Altered d-Aspartate Metabolism in Schizophrenia: New Insights From Preclinical Models and Human Studies.
Errico F; Nuzzo T; Carella M; Bertolino A; Usiello A
Front Psychiatry; 2018; 9():559. PubMed ID: 30459655
[TBL] [Abstract][Full Text] [Related]
4. D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801.
Errico F; Rossi S; Napolitano F; Catuogno V; Topo E; Fisone G; D'Aniello A; Centonze D; Usiello A
J Neurosci; 2008 Oct; 28(41):10404-14. PubMed ID: 18842900
[TBL] [Abstract][Full Text] [Related]
5. Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia.
Errico F; Napolitano F; Squillace M; Vitucci D; Blasi G; de Bartolomeis A; Bertolino A; D'Aniello A; Usiello A
J Psychiatr Res; 2013 Oct; 47(10):1432-7. PubMed ID: 23835041
[TBL] [Abstract][Full Text] [Related]
6. A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice.
Errico F; D'Argenio V; Sforazzini F; Iasevoli F; Squillace M; Guerri G; Napolitano F; Angrisano T; Di Maio A; Keller S; Vitucci D; Galbusera A; Chiariotti L; Bertolino A; de Bartolomeis A; Salvatore F; Gozzi A; Usiello A
Transl Psychiatry; 2015 Feb; 5(2):e512. PubMed ID: 25689573
[TBL] [Abstract][Full Text] [Related]
7. D-aspartate: an atypical amino acid with neuromodulatory activity in mammals.
Errico F; Napolitano F; Nisticò R; Centonze D; Usiello A
Rev Neurosci; 2009; 20(5-6):429-40. PubMed ID: 20397623
[TBL] [Abstract][Full Text] [Related]
8. Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia.
Errico F; Bonito-Oliva A; Bagetta V; Vitucci D; Romano R; Zianni E; Napolitano F; Marinucci S; Di Luca M; Calabresi P; Fisone G; Carta M; Picconi B; Gardoni F; Usiello A
Exp Neurol; 2011 Dec; 232(2):240-50. PubMed ID: 21946266
[TBL] [Abstract][Full Text] [Related]
9. Age-Related Changes in D-Aspartate Oxidase Promoter Methylation Control Extracellular D-Aspartate Levels and Prevent Precocious Cell Death during Brain Aging.
Punzo D; Errico F; Cristino L; Sacchi S; Keller S; Belardo C; Luongo L; Nuzzo T; Imperatore R; Florio E; De Novellis V; Affinito O; Migliarini S; Maddaloni G; Sisalli MJ; Pasqualetti M; Pollegioni L; Maione S; Chiariotti L; Usiello A
J Neurosci; 2016 Mar; 36(10):3064-78. PubMed ID: 26961959
[TBL] [Abstract][Full Text] [Related]
10. D-aspartate dysregulation in Ddo(-/-) mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum.
de Bartolomeis A; Errico F; Aceto G; Tomasetti C; Usiello A; Iasevoli F
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Oct; 62():35-43. PubMed ID: 25979765
[TBL] [Abstract][Full Text] [Related]
11. d-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brain.
Cristino L; Luongo L; Squillace M; Paolone G; Mango D; Piccinin S; Zianni E; Imperatore R; Iannotta M; Longo F; Errico F; Vescovi AL; Morari M; Maione S; Gardoni F; Nisticò R; Usiello A
Neurobiol Aging; 2015 May; 36(5):1890-902. PubMed ID: 25771393
[TBL] [Abstract][Full Text] [Related]
12. Persistent elevation of D-Aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons.
Krashia P; Ledonne A; Nobili A; Cordella A; Errico F; Usiello A; D'Amelio M; Mercuri NB; Guatteo E; Carunchio I
Neuropharmacology; 2016 Apr; 103():69-78. PubMed ID: 26707656
[TBL] [Abstract][Full Text] [Related]
13. Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals.
Errico F; Nisticò R; Di Giorgio A; Squillace M; Vitucci D; Galbusera A; Piccinin S; Mango D; Fazio L; Middei S; Trizio S; Mercuri NB; Teule MA; Centonze D; Gozzi A; Blasi G; Bertolino A; Usiello A
Transl Psychiatry; 2014 Jul; 4(7):e417. PubMed ID: 25072322
[TBL] [Abstract][Full Text] [Related]
14. Bimodal effect of D-aspartate on brain aging processes: insights from animal models.
Errico F; Di Maio A; Marsili V; Squillace M; Vitucci D; Napolitano F; Usiello A
J Biol Regul Homeost Agents; 2013; 27(2 Suppl):49-59. PubMed ID: 24813315
[TBL] [Abstract][Full Text] [Related]
15. New insights on the influence of free d-aspartate metabolism in the mammalian brain during prenatal and postnatal life.
Errico F; Cuomo M; Canu N; Caputo V; Usiello A
Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140471. PubMed ID: 32561430
[TBL] [Abstract][Full Text] [Related]
16. Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain.
Strick CA; Li C; Scott L; Harvey B; Hajós M; Steyn SJ; Piotrowski MA; James LC; Downs JT; Rago B; Becker SL; El-Kattan A; Xu Y; Ganong AH; Tingley FD; Ramirez AD; Seymour PA; Guanowsky V; Majchrzak MJ; Fox CB; Schmidt CJ; Duplantier AJ
Neuropharmacology; 2011; 61(5-6):1001-15. PubMed ID: 21763704
[TBL] [Abstract][Full Text] [Related]
17. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Javitt DC
Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
[TBL] [Abstract][Full Text] [Related]
18. Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients.
Nuzzo T; Sacchi S; Errico F; Keller S; Palumbo O; Florio E; Punzo D; Napolitano F; Copetti M; Carella M; Chiariotti L; Bertolino A; Pollegioni L; Usiello A
NPJ Schizophr; 2017; 3():16. PubMed ID: 28560262
[TBL] [Abstract][Full Text] [Related]
19. D-Amino acids in the brain and mutant rodents lacking D-amino-acid oxidase activity.
Yamanaka M; Miyoshi Y; Ohide H; Hamase K; Konno R
Amino Acids; 2012 Nov; 43(5):1811-21. PubMed ID: 22892863
[TBL] [Abstract][Full Text] [Related]
20. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
